Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Carna Biosciences

Market Cap: JP¥5.4b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Kringle Pharma

Market Cap: JP¥5.7b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

Kissei Pharmaceutical

Market Cap: JP¥159.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

CellSource

Market Cap: JP¥12.5b

Engages in the regenerative medicine-related businesses in Japan.

CanBas

Market Cap: JP¥24.5b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

Daiichi Sankyo Company

Market Cap: JP¥7.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥12.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Solasia Pharma K.K

Market Cap: JP¥6.5b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

Takara Bio

Market Cap: JP¥90.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Ribomic

Market Cap: JP¥3.8b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

TMS

Market Cap: JP¥6.3b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

DNA Chip Research

Market Cap: JP¥7.3b

Develops DNA microarrays in Japan.

Veritas In Silico

Market Cap: JP¥4.3b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Santen Pharmaceutical

Market Cap: JP¥536.3b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Noile-Immune Biotech

Market Cap: JP¥6.9b

Researches and develops CAR-T cells for cancer immunotherapies.

FunPep

Market Cap: JP¥3.6b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

Nippon Shinyaku

Market Cap: JP¥232.7b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Chordia Therapeutics

Market Cap: JP¥15.6b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

ReproCELL

Market Cap: JP¥15.3b

Provides stem cell research and drug discovery services in Japan.

WDB coco

Market Cap: JP¥6.9b

Provides contract services to pharmaceutical companies in Japan.

Delta-Fly Pharma

Market Cap: JP¥5.6b

Develops anticancer drugs.

Seikagaku

Market Cap: JP¥34.9b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Immuno-Biological Laboratories

Market Cap: JP¥4.7b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Tsumura

Market Cap: JP¥263.0b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥66.7b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Perseus Proteomics

Market Cap: JP¥6.6b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

OncoTherapy Science

Market Cap: JP¥6.3b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

SanBio

Market Cap: JP¥227.9b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

MedRx

Market Cap: JP¥2.9b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Modalis Therapeutics

Market Cap: JP¥5.7b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Heartseed

Market Cap: JP¥55.9b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Renascience

Market Cap: JP¥20.5b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

StemRIM

Market Cap: JP¥18.7b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Kaken Pharmaceutical

Market Cap: JP¥141.5b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.